A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax

por Kako, Satoko, Joshita, Satoru, Matsuo, Akemi, Kawaguchi, Kenji, Umemura, Takeji, Tanaka, Eiji
Publicado 2019

Vaginal delivery after improvement in COVID-19 by monoclonal antibody treatment: A case report and literature review

por Ogawa, Eisuke, Goto, Hirohisa, Ushimaru, Hiroyasu, Matsuo, Akemi, Takeda, Satoshi, Nishimura, Ryohei, Hondo, Takaaki, Takahashi, Takashi
Publicado 2022

Serial Cancer Development Three Times in a Patient with Fanconi Anemia

por Yanagisawa, Katsuya, Horiuchi, Toshimichi, Matsuo, Akemi, Kuraishi, Hiroshi, Satomi, Hidetoshi, Ito, Ichiro, Noguchi, Takuro, Sekiguchi, Nodoka, Kanda, Shintaro, Koizumi, Tomonobu
Publicado 2021

C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective s...

por Sonehara, Kei, Ozawa, Ryota, Hama, Mineyuki, Nozawa, Shuhei, Agatsuma, Toshihiko, Nishie, Kenichi, Kato, Akane, Matsuo, Akemi, Araki, Taisuke, Komatsu, Masamichi, Tateishi, Kazunari, Hanaoka, Masayuki
Publicado 2023

The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019()

por Goto, Norihiko, Wada, Yosuke, Ikuyama, Yuichi, Akahane, Jumpei, Kosaka, Makoto, Ushiki, Atsuhito, Kitaguchi, Yoshiaki, Yasuo, Masanori, Yamamoto, Hiroshi, Matsuo, Akemi, Hachiya, Tsutomu, Ideura, Gen, Yamazaki, Yoshitaka, Hanaoka, Masayuki
Publicado 2021

Clinical analysis of EGFR‐positive non‐small cell lung cancer patients treated with first‐line afatinib: A Nagano Lung Cancer Research Group

por Sonehara, Kei, Kobayashi, Takashi, Tateishi, Kazunari, Morozumi, Nobutoshi, Yoshiike, Fumiaki, Hachiya, Tsutomu, Ono, Yasushi, Takasuna, Keiichirou, Agatsuma, Toshihiko, Masubuchi, Takeshi, Matsuo, Akemi, Tanaka, Hozumi, Morikawa, Akio, Hanaoka, Masayuki, Koizumi, Tomonobu
Publicado 2019

Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)

por Araki, Taisuke, Kanda, Shintaro, Komatsu, Masamichi, Sonehara, Kei, Tateishi, Kazunari, Takada, Munetake, Kato, Akane, Yamamoto, Manabu, Nishie, Kenichi, Hama, Mineyuki, Agatsuma, Toshihiko, Kakizaki, Yumiko, Yoshiike, Fumiaki, Matsuo, Akemi, Chiaki, Tomoshige, Samizo, Kanae, Takagi, Yoshiko, Yamaura, Maki, Hanaoka, Masayuki, Koizumi, Tomonobu
Publicado 2023